We are live on ! Find out more
CVRS

CORINDUS VASCULAR ROBOTICS, INC
CVRS

Delisted

CVRS was delisted on the 28th of October, 2019.

58 hedge funds and large institutions have $99M invested in CORINDUS VASCULAR ROBOTICS, INC in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 10

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

7% more funds holding

Funds holding: 5458 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

19% less capital invested

Capital invested by funds: $123M → $99M (-$23.6M)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
26
Reduced
10
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Nomura Holdings
26
Nomura Holdings
Japan
$119K +$131K +78,233 New
CS
27
Credit Suisse
Switzerland
$101K +$78.5K +46,833 +235%
KLI
28
Kelman-Lazarov Inc
Tennessee
$86K +$34.3K +20,500 +57%
AIG
29
American International Group
New York
$85K +$7.04K +4,204 +8%
VOYA Investment Management
30
VOYA Investment Management
Georgia
$79K
NFA
31
Nationwide Fund Advisors
Ohio
$72K
Wells Fargo
32
Wells Fargo
California
$65K +$11.7K +6,968 +20%
RJFSA
33
Raymond James Financial Services Advisors
Florida
$59K +$41K +24,500 +175%
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$58K +$62.6K +37,379 +4,398%
GC
35
Guggenheim Capital
Illinois
$55K +$22.2K +13,228 +57%
AllianceBernstein
36
AllianceBernstein
Tennessee
$47K
Tudor Investment Corp
37
Tudor Investment Corp
Connecticut
$37K -$5.27K -3,145 -11%
Legal & General Group
38
Legal & General Group
United Kingdom
$33K +$16.1K +9,639 +79%
State Board of Administration of Florida Retirement System
39
State Board of Administration of Florida Retirement System
Florida
$29K +$33.1K +19,740 New
VF
40
Virtu Financial
New York
$24K +$26K +15,538 New
N
41
Natixis
France
$22K +$24.4K +14,553 New
CA
42
Cetera Advisors
Colorado
$20K
AB
43
Amalgamated Bank
New York
$19K +$4.62K +2,756 +27%
TRCT
44
Tower Research Capital (TRC)
New York
$18K +$18.7K +11,159 +2,861%
SG Americas Securities
45
SG Americas Securities
New York
$17K -$12.7K -7,594 -40%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$16.8K +$8.4K +5,014 +83%
SPIA
47
Steward Partners Investment Advisory
New York
$16K
EAM
48
Evanson Asset Management
California
$15K
AIP
49
Ameritas Investment Partners
Nebraska
$14K
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$12K +$13.3K +7,951 +3,383%

CVRS Hedge Fund Activity: Q3 2017 in Review

58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q3 2017, worth a combined $99M — down 19% from $123M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CVRS positions and 5 closed out — a net gain of 4 holders — while 26 added to existing stakes and 10 trimmed.

The largest buyer was Essex Investment Management, opening a new position worth an estimated $1.34M. The largest seller was Consonance Capital Management, cutting an estimated $5.45M.

  • 58 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q3 2017, up from 54 in Q2 2017.
  • Funds reported $99M of CORINDUS VASCULAR ROBOTICS, INC stock for Q3 2017, down 19% quarter-over-quarter.
  • 9 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q3 2017 and 5 closed out, a net change of +4 holders.
  • The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q3 2017 was Essex Investment Management, an estimated $1.34M added.
  • The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q3 2017 was Consonance Capital Management, an estimated $5.45M sold.

Based on aggregated 13F filings for Q3 2017.